With the prevalence of diabetes continuing to grow in many countries, it is one of the most serious chronic health challenges we face today.
adults worldwide have diabetes.
Type 2 diabetes accounts for approximately
of all cases of diagnosed diabetes in adults.
Diabetes is the
leading cause of death in the U.S. and the sixth worldwide.
Diabetes is one of Merck’s top therapeutic priorities and a point of passion for many colleagues at Merck, both personally and professionally.
Karen, a Merck employee, shares her own experience living with type 2 diabetes.
LEADERSHIP THROUGH INNOVATION AND COLLABORATION
“Advancements in diabetes research are making a remarkable difference for patients, but there is much more work to be done. At Merck, we strive for scientific excellence and innovation in all stages of diabetes research, from discovery through approval and afterwards. I am proud to be part of a research team that is committed to doing something truly meaningful to help people with diabetes.”
America's Diabetes Challenge: Get to Your Goals is a Merck-sponsored program created with the American Diabetes Association to raise awareness among people with type 2 diabetes about the importance of working with their doctors to set and reach their A1C goals. The program also aims to help people learn if they are at risk of low blood glucose and how to help reduce that risk.
In 2016, the Merck Foundation launched a new initiative, Bridging the Gap: Reducing Disparities in Diabetes Care, to improve access to high-quality diabetes care and reduce health disparities in vulnerable and underserved communities in the United States.
With $16 million in funding from the Foundation over five years, Bridging the Gap will support multifaceted diabetes programs in selected communities around the country, with a goal of promoting best practices in primary care transformation and advancing intersectoral collaborations to reduce diabetes disparities.